DIAJARD M 12.5/500MG TAB NEW

DIAJARD M combines empagliflozin and metformin to help manage type 2 diabetes effectively. Empagliflozin works by removing excess glucose through urine, while metformin improves insulin sensitivity and reduces glucose production. This dual-action formula supports better blood sugar control and may help reduce cardiovascular risk. Each tablet contains 12.5mg empagliflozin and 500mg metformin. Take as directed by your healthcare provider. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient.